Drug company Pfizer has announced it is to close down its last pharmaceutical-ingredients manufacturing plant in the UK with the loss of 420 jobs, including 30 IT roles related to process automation and business systems support.
By submitting your personal information, you agree that TechTarget and its partners may contact you regarding relevant content, products and special offers.
Pfizer said the decision to phase out its manufacturing plant at Sandwich in Kent after 53 years is part of the company's plans to consolidate worldwide manufacturing operations. Operations at the plant will be phased out over the next two years. Pfizer said affected staff would be redeployed where possible.
However, the company said its research facility at Sandwich, which employs 3,000 people, was not affected by the decision and would remain one of Pfizer's four key global research and development programmes.
Tony Maddaluna, vice-president of Pfizer Global Manufacturing said: "This is the latest in a number of global manufacturing changes, to ensure we are operating as efficiently and effectively as possible."